경남제약

경남제약 is a declared insider of 한주에이알티, with filings sourced from DART (FSS). Over a trading history stretching from 22 March 2023 to 2 May 2025, the count stands at 26 filings.

Sales make up the whole of the open-market record (5 sales). The amount is not disclosed for 5 filings. 2025 to date brings no purchases and 1 sale.

The latest filing, published on 9 May 2025, reports an open-market sale in 한주에이알티. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.